表紙
市場調査レポート

形質細胞腫瘍:世界の治験レビュー

Plasma Cell Neoplasm Global Clinical Trials Review, H1, 2012

発行 GlobalData 商品コード 230797
出版日 ページ情報 英文 130 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
形質細胞腫瘍:世界の治験レビュー Plasma Cell Neoplasm Global Clinical Trials Review, H1, 2012
出版日: 2012年01月27日 ページ情報: 英文 130 Pages
概要

当レポートでは、世界の形質細胞腫瘍治療薬の臨床試験について調査し、地域別の臨床市件数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 形質細胞腫瘍
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している上位5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位国 − 中東およびアフリカ
    • 臨床試験に寄与している上位国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 臨床試験:相別
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:上位企業
      • Oncotherapeutics
      • PrECOG, LLC.
      • Janssen Biotech, Inc.
      • Cell Medica Limited
      • Cellerant Therapeutics, Inc.
      • Array BioPharma Inc.
      • Genzyme Corporation
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • Mayo Clinic
      • Fred Hutchinson Cancer Research Center
      • Southwest Oncology Group
      • Memorial Sloan Kettering Cancer Center
      • Masonic Cancer Center
      • Boston Medical Center
      • City of Hope National Medical Center
      • Barbara Ann Karmanos Cancer Institute
      • Vanderbilt-Ingram Cancer Center
      • OHSU Knight Cancer Institute
      • Case Comprehensive Cancer Center
      • H. Lee Moffitt Cancer Center & Research Institute
      • Northwestern University
      • The Cleveland Clinic
      • UNC Lineberger Comprehensive Cancer Center
      • University of Medicine and Dentistry New Jersey
      • Sidney Kimmel Comprehensive Cancer Center
      • Roswell Park Cancer Institute
      • The University of Maryland
      • Herbert Irving Comprehensive Cancer Center
  • 5件の主要な臨床プロファイル

付録

図表一覧


目次

Summary

GlobalData's clinical trial report, "Plasma Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Plasma Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Plasma Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Plasma Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Plasma Cell Neoplasm
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Plasma Cell Neoplasm
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Plasma Cell Neoplasm Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Oncotherapeutics
      • Clinical Trial Overview of Oncotherapeutics
      • PrECOG, LLC.
      • Clinical Trial Overview of PrECOG, LLC.
      • Janssen Biotech, Inc.
      • Clinical Trial Overview of Janssen Biotech, Inc.
      • Cell Medica Limited
      • Clinical Trial Overview of Cell Medica Limited
      • Cellerant Therapeutics, Inc.
      • Clinical Trial Overview of Cellerant Therapeutics, Inc.
      • Array BioPharma Inc.
      • Clinical Trial Overview of Array BioPharma Inc.
      • Genzyme Corporation
      • Clinical Trial Overview of Genzyme Corporation
    • Clinical Trial Overview of Top Universities / Institutes / Hospitals
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • Southwest Oncology Group
      • Clinical Trial Overview of Southwest Oncology Group
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Masonic Cancer Center
      • Clinical Trial Overview of Masonic Cancer Center
      • Boston Medical Center
      • Clinical Trial Overview of Boston Medical Center
      • City of Hope National Medical Center
      • Clinical Trial Overview of City of Hope National Medical Center
      • Barbara Ann Karmanos Cancer Institute
      • Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
      • Vanderbilt-Ingram Cancer Center
      • Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
      • OHSU Knight Cancer Institute
      • Clinical Trial Overview of OHSU Knight Cancer Institute
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • H. Lee Moffitt Cancer Center & Research Institute
      • Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • The Cleveland Clinic
      • Clinical Trial Overview of The Cleveland Clinic
      • UNC Lineberger Comprehensive Cancer Center
      • Clinical Trial Overview of UNC Lineberger Comprehensive Cancer Center
      • University of Medicine and Dentistry New Jersey
      • Clinical Trial Overview of University of Medicine and Dentistry New Jersey
      • Sidney Kimmel Comprehensive Cancer Center
      • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • The University of Maryland
      • Clinical Trial Overview of The University of Maryland
      • Herbert Irving Comprehensive Cancer Center
      • Clinical Trial Overview of Herbert Irving Comprehensive Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Zone, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, North America, Top Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, BRIC Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, G7 Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, E7 Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Phase, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Suspended Clinical Trials, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Terminated Clinical Trials, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncotherapeutics, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by PrECOG, LLC., 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Biotech, Inc., 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Medica Limited, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Cellerant Therapeutics, Inc., 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Array BioPharma Inc., 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by UNC Lineberger Comprehensive Cancer Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Maryland, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Herbert Irving Comprehensive Cancer Center, 2012*

List of Figures

  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, BRIC Countries (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, G7 Countries (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, E7 Countries (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
  • Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • GlobalData Methodology
Back to Top